| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 16 | |
| #2 | WIPO (World Intellectual Property Organization) | 8 | |
| #3 | EPO (European Patent Office) | 7 | |
| #4 | China | 6 | |
| #5 | Mexico | 5 | |
| #6 | Canada | 4 | |
| #7 | Brazil | 3 | |
| #8 | New Zealand | 3 | |
| #9 | African Regional Industrial Property Organization | 2 | |
| #10 | Hungary | 2 | |
| #11 | Serbia | 2 | |
| #12 | Singapore | 2 | |
| #13 | Australia | 1 | |
| #14 | Chile | 1 | |
| #15 | EAPO (Eurasian Patent Organization) | 1 | |
| #16 | United Kingdom | 1 | |
| #17 | Hong Kong | 1 | |
| #18 | Israel | 1 | |
| #19 | Japan | 1 | |
| #20 | Republic of Korea | 1 | |
| #21 | Morocco | 1 | |
| #22 | Montenegro | 1 | |
| #23 | Peru | 1 | |
| #24 | Philippines | 1 | |
| #25 | Tunisia | 1 | |
| #26 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Griswold-Prenner Irene | 49 |
| #2 | Stagliano Nancy E | 37 |
| #3 | Dang Vu | 26 |
| #4 | Dang Vu Cao | 13 |
| #5 | Parry Graham | 10 |
| #6 | Irene Griswold-Prenner | 10 |
| #7 | Hussain Sami | 9 |
| #8 | Sakurada Kazuhiro | 8 |
| #9 | Bright Jessica Michelle | 8 |
| #10 | Masaki Hideki | 7 |
| Publication | Filing date | Title |
|---|---|---|
| JP2019089763A | Tau peptides, anti-tau antibodies, and use methods thereof | |
| CN105899230A | Methods of treating a tauopathy | |
| US2016122421A1 | Methods of treating a tauopathy | |
| CN105339002A | Methods of treating tauopathy | |
| US2016347804A1 | Tau peptides, anti-tau antibodies, and methods of use thereof | |
| US2014234214A1 | Methods of treating a tauopathy | |
| AU2013302540A1 | Methods of treating a tauopathy | |
| WO2013169793A2 | Methods and compositions for tdp-43 proteinopathies | |
| WO2011143343A1 | Integration-free human induced pluripotent stem cells from blood | |
| US2011020814A1 | Methods and compositions for selection of stem cells | |
| WO2010102267A2 | Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells |